Changes in quality of life and its related factors in liver cancer patients receiving stereotactic radiation therapy. Support Care Cancer. 2008;16:1059-1065. [PMID: 18197433 DOI: 10.1016/j.ijrobp.2008.06.1460]

Application of 18F-FDG PET/CT imaging in stereotactic radiotherapy of colorectal liver metastases

Colorectal cancer (CRC) is a common digestive malignant tumor. Liver metastasis is a frequent event in CRC patients. Although there has been a consensus about the treatment of CRC primary tumor, the treatment of CRC liver metastasis is in great dispute. Emerging recommendation is that CRC liver metastases do not absolutely indicate systemic metastasis, so patients with CRC liver metastases should be treated appropriately. A good therapeutic effect can enhance the curative effect and life quality. This article is intended to discuss the application of PET/CT in the precise radiotherapy of colorectal liver metastases.